Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes
المؤلفون المشاركون
Zhao, Ming-hui
Wu, Shouling
Liu, Lili
Gao, Bixia
Wang, Jinwei
Yang, Chao
Wu, Yuntao
Chen, Shuohua
Li, Qiuyun
Zhang, Huifen
Wang, Guodong
Chen, Min
Zhang, Luxia
المصدر
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-06-10
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Objective.
We aimed to evaluate whether the reduction in serum high-sensitivity C-reactive protein (hs-CRP) favors kidney outcomes.
Methods.
This study was a subanalysis including patients with impaired fasting glucose or diabetes of the Kailuan cohort study.
The predictor was based on two consecutive visits of hs-CRP levels in 2006 and 2008.
A total of 3924 patients with hs-CRP≥3 mg/L in 2006 were divided into two groups according to whether the levels of hs-CRP were reduced in 2008: Group 1: no reduction: hs-CRP≥3 mg/L in 2008; Group 2: reduction: hs-CRP<3 mg/L in 2008.
Kidney outcomes include kidney function decline and development and progression of proteinuria and were followed up until the end of 2015.
Results.
There were 3905, 2049, and 493 patients included into our analysis for the outcomes of kidney function decline and the development and progression of proteinuria, respectively.
A total of 398, 297, and 47 events occurred after 5 years of follow-up, respectively.
Cox regression revealed that patients with reduction in hs-CRP have lower risk of kidney function decline (HR 0.71, 95% CI 0.57-0.89, and P=0.002) and development of proteinuria (0.77, 0.61-0.99, and P=0.038) after controlling for potential confounders as compared to those with no reduction in hs-CRP levels.
Conclusions.
Reduction in serum hs-CRP levels favors kidney outcomes in patients with impaired fasting glucose or diabetes.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Liu, Lili& Gao, Bixia& Wang, Jinwei& Yang, Chao& Wu, Shouling& Wu, Yuntao…[et al.]. 2020. Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes. Journal of Diabetes Research،Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1182977
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Liu, Lili…[et al.]. Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes. Journal of Diabetes Research No. 2020 (2020), pp.1-7.
https://search.emarefa.net/detail/BIM-1182977
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Liu, Lili& Gao, Bixia& Wang, Jinwei& Yang, Chao& Wu, Shouling& Wu, Yuntao…[et al.]. Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes. Journal of Diabetes Research. 2020. Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1182977
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1182977
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر